0.76 / 0.82%
Latest price in EURToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Mar 31 2015 13:20 BST.


As of last trade Sanofi SA (SAN:PAR) traded at 91.94, 2.61 % below its 52-week high of 94.40, set on Mar 24, 2015.

52-week range
Oct 29 2014
Mar 24 2015
Markit short selling activity
Day high93.46
Day low91.77
Previous close92.70
Average volume3.27m
Shares outstanding1.32bn
Free float1.19bn
P/E (TTM)27.89
Market cap122.74bn EUR
Annual div (IAD)2.85 EUR
Annual div yield (IAD)3.07%
Div ex-dateMay 12 2014
Div pay-dateMay 15 2014
Next div ex-dateMay 11 2015
Next div pay-dateMay 13 2015
Data delayed at least 15 minutes, as of Mar 31 2015 13:20 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Sanofi SA-2.23 %+4.83 %+2.66 %+21.49 %+66.59 %
CAC 40 INDEX-1.01 %+1.72 %+14.05 %+14.69 %+26.74 %
FR/HEALTH CARE-2.08 %+3.92 %+6.98 %+19.49 %+42.07 %
FR/PHARMACEUTICALS-2.12 %+4.35 %+4.45 %+17.33 %+39.21 %
Data delayed at least 15 minutes, as of Mar 31 2015 13:20 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.